The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dilsan Pharma Impex Pvt Ltd
Rekvina Laboratories Ltd. Press Release Feb 21 2025
Filed with BSE ·
6ix hasn’t read this filing yet.
Rekvina Laboratories Ltd. on 6ix
Earlier from Rekvina Laboratories
- Rekvina Laboratories Ltd. Press Release Feb 18 2025
- Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
- Rekvina Laboratories Ltd. Press Release Jan 30 2025
- Integrated Filing (Financial)
- Rekvina Laboratories Ltd. Press Release Jan 20 2025
Later from Rekvina Laboratories
- Closure of Trading Window
- Rekvina Laboratories Ltd. Press Release Mar 26 2025
- Rekvina Laboratories Ltd. Press Release Mar 27 2025
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Rekvina Laboratories Ltd. Press Release Apr 07 2025
Follow Rekvina Laboratories into a list and get an email when it puts out news.
Follow Rekvina Laboratories